Skip to content

Brimonidine Impurity 15

Brimonidine Impurity 15

Product Description
CAT No.
ALN-B026043
CAS No.
NA
Mol. F.
C16H12BrN5O5
Mol. Wt.
434.2
Stock
Please Inquire
RFQ
Chemical Name : (E)-2-(N-(5-Bromoquinoxalin-6-yl)-3-carboxyacrylamido)-4,5-dihydro-1H-imidazole-1-carboxylic acid
Smiles : BrC1=C(N(C2=NCCN2C(O)=O)C(/C=C/C(O)=O)=O)C=CC3=C1N=CC=N3
Inchi : InChI=1/C20H28NO.ClH/c1-5-21(3,4)15-16-22-20(18-12-7-6-8-13-18)19-14-10-9-11-17(19)2;/h6-14,20H,5,15-16H2,1-4H3;1H/q+1;/p-1

Sustained reduction of intraocular pressure by supraciliary delivery of brimonidine-loaded poly(lactic acid) microspheres for the treatment of glaucoma

B.Chianga1Y.C.Kimb1A.C.Dotyc12H.E.GrossniklausdS.P.SchwendemancM.R.PrausnitznJournal of Controlled Release Volume 228, 28 April 2016, Pages 48-57

Sustained release of brimonidine from a new composite drug delivery system for treatment of glaucoma

Jianguo Sun, Yuan Lei, Zhaoxing Dai∥, Xi Liu, Taomin Huang, Jihong Wu, Zhi Ping XOrcid, and Xinghuai Sun – ACS Appl. Mater. Interfaces 2017, 9, 9, 7990–7999

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems

Jianguo Sun, Xiuwen Zhang & Taomin Huang – Chemistry Central Journal volume 11, Article number: 62 (2017)

Request For Quotation

Related Products